Logo_Biofrontera_AG.png
Biofrontera strengthens commercial focus with reorganization of its US business
06 janv. 2020 09h00 HE | Biofrontera AG
Leverkusen, Germany, Jan. 06, 2020 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced a new...
Logo_Biofrontera_AG.png
Christopher Pearson appointed new Chief Commercial Officer at US subsidiary Biofrontera Inc.
13 déc. 2019 08h20 HE | Biofrontera AG
Leverkusen, Germany, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announced today that...